Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program

Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program

Apparent treatment-resistant hypertension (ATRH) has been linked to end-stage kidney disease (ESKD) and cardiovascular disease. We tested the hypothesis that the effect of ATRH on ESKD is greater in Black patients than in White patients and investigated the effect of ATRH on ESKD independent of APOL...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2021-06
Hauptverfasser: Akwo, Elvis A., Robinson-Cohen, Cassianne, Chung, Cecilia P., Shah, Shailja C., Brown, Nancy J., Ikizler, T. Alp, Wilson, Otis D., Rowan, Bryce X., Shuey, Megan M., Siew, Edward D., Luther, James M., Giri, Ayush, Hellwege, Jacklyn N., Velez Edwards, Digna R., Roumie, Christianne L., Tao, Ran, Tsao, Phil S., Gaziano, J. Michael, Wilson, Peter W.F., O’Donnell, Christopher J., Edwards, Todd L., Kovesdy, Csaba P., Hung, Adriana M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Apparent treatment-resistant hypertension (ATRH) has been linked to end-stage kidney disease (ESKD) and cardiovascular disease. We tested the hypothesis that the effect of ATRH on ESKD is greater in Black patients than in White patients and investigated the effect of ATRH on ESKD independent of APOL1 genotype. In a retrospective cohort of 139 685 hypertensive veterans (22% Black, 5% women) in the Million Veteran Program, ATRH was defined as failure to achieve outpatient blood pressure
ISSN:0194-911X
DOI:10.1161/HYPERTENSIONAHA.120.16181